234 related articles for article (PubMed ID: 34504347)
21. Construction of a reference material panel for detecting
Xu J; Qu S; Sun N; Zhang W; Zhang J; Song Q; Lin M; Gao W; Zheng Q; Han M; Na C; Xu R; Chang X; Yang X; Huang J
J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
[TBL] [Abstract][Full Text] [Related]
22. Influence of low tumor content on tumor mutational burden estimation by whole-exome sequencing and targeted panel sequencing.
Zhang W; Wang R; Fang H; Ma X; Li D; Liu T; Chen Z; Wang K; Hao S; Yu Z; Chang Z; Na C; Wang Y; Bai J; Zhang Y; Chen F; Li M; Chen C; Wei L; Li J; Chang X; Qu S; Yang L; Huang J
Clin Transl Med; 2021 May; 11(5):e415. PubMed ID: 34047470
[TBL] [Abstract][Full Text] [Related]
23. Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
Vendrell JA; Vilquin P; Larrieux M; Van Goethem C; Solassol J
J Mol Diagn; 2018 Nov; 20(6):754-764. PubMed ID: 30055349
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive benchmarking of SNV callers for highly admixed tumor data.
Bohnert R; Vivas S; Jansen G
PLoS One; 2017; 12(10):e0186175. PubMed ID: 29020110
[TBL] [Abstract][Full Text] [Related]
25. Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome Patients.
Palomo L; Fuster-Tormo F; Alvira D; Ademà V; Armengol MP; Gómez-Marzo P; de Haro N; Mallo M; Xicoy B; Zamora L; Solé F
Biopreserv Biobank; 2017 Aug; 15(4):360-365. PubMed ID: 28586236
[TBL] [Abstract][Full Text] [Related]
26. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
27. A somatic reference standard for cancer genome sequencing.
Craig DW; Nasser S; Corbett R; Chan SK; Murray L; Legendre C; Tembe W; Adkins J; Kim N; Wong S; Baker A; Enriquez D; Pond S; Pleasance E; Mungall AJ; Moore RA; McDaniel T; Ma Y; Jones SJ; Marra MA; Carpten JD; Liang WS
Sci Rep; 2016 Apr; 6():24607. PubMed ID: 27094764
[TBL] [Abstract][Full Text] [Related]
28. Quartet DNA reference materials and datasets for comprehensively evaluating germline variant calling performance.
Ren L; Duan X; Dong L; Zhang R; Yang J; Gao Y; Peng R; Hou W; Liu Y; Li J; Yu Y; Zhang N; Shang J; Liang F; Wang D; Chen H; Sun L; Hao L; ; Scherer A; Nordlund J; Xiao W; Xu J; Tong W; Hu X; Jia P; Ye K; Li J; Jin L; Hong H; Wang J; Fan S; Fang X; Zheng Y; Shi L
Genome Biol; 2023 Nov; 24(1):270. PubMed ID: 38012772
[TBL] [Abstract][Full Text] [Related]
29. Comparison between MGI and Illumina sequencing platforms for whole genome sequencing.
Jeon SA; Park JL; Park SJ; Kim JH; Goh SH; Han JY; Kim SY
Genes Genomics; 2021 Jul; 43(7):713-724. PubMed ID: 33864614
[TBL] [Abstract][Full Text] [Related]
30. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W
Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study.
Cheng HF; Tsai YF; Liu CY; Hsu CY; Lien PJ; Lin YS; Chao TC; Lai JI; Feng CJ; Chen YJ; Chen BF; Chiu JH; Tseng LM; Huang CC
Breast Cancer Res; 2023 Dec; 25(1):152. PubMed ID: 38098088
[TBL] [Abstract][Full Text] [Related]
32. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
[TBL] [Abstract][Full Text] [Related]
33. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
34. A three-caller pipeline for variant analysis of cancer whole-exome sequencing data.
Liu ZK; Shang YK; Chen ZN; Bian H
Mol Med Rep; 2017 May; 15(5):2489-2494. PubMed ID: 28447726
[TBL] [Abstract][Full Text] [Related]
35. Reliable Analysis of Clinical Tumor-Only Whole-Exome Sequencing Data.
Oh S; Geistlinger L; Ramos M; Morgan M; Waldron L; Riester M
JCO Clin Cancer Inform; 2020 Apr; 4():321-335. PubMed ID: 32282230
[TBL] [Abstract][Full Text] [Related]
36. Improving the Performance of Somatic Mutation Identification by Recovering Circulating Tumor DNA Mutations.
Fu Y; Jovelet C; Filleron T; Pedrero M; Motté N; Boursin Y; Luo Y; Massard C; Campone M; Levy C; Diéras V; Bachelot T; Garrabey J; Soria JC; Lacroix L; André F; Lefebvre C
Cancer Res; 2016 Oct; 76(20):5954-5961. PubMed ID: 27535334
[TBL] [Abstract][Full Text] [Related]
37. Preparation of multiplexed control materials for cancer mutation analysis by genome editing in GM12878 cells.
Lin G; Zhang K; Han Y; Peng R; Li J
J Clin Lab Anal; 2022 Jan; 36(1):e24139. PubMed ID: 34811797
[TBL] [Abstract][Full Text] [Related]
38. Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma.
Roberts HE; Lopopolo M; Pagnamenta AT; Sharma E; Parkes D; Lonie L; Freeman C; Knight SJL; Lunter G; Dreau H; Lockstone H; Taylor JC; Schuh A; Bowden R; Buck D
Sci Rep; 2021 Mar; 11(1):6408. PubMed ID: 33742045
[TBL] [Abstract][Full Text] [Related]
39. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
[TBL] [Abstract][Full Text] [Related]
40. A practical guide for mutational signature analysis in hematological malignancies.
Maura F; Degasperi A; Nadeu F; Leongamornlert D; Davies H; Moore L; Royo R; Ziccheddu B; Puente XS; Avet-Loiseau H; Campbell PJ; Nik-Zainal S; Campo E; Munshi N; Bolli N
Nat Commun; 2019 Jul; 10(1):2969. PubMed ID: 31278357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
